2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study
Bakaloudi D, Koehne E, Diamantopoulos L, Holt S, Sekar R, Ghali F, Vakar-Lopez F, Nyame Y, Psutka S, Gore J, de la Calle C, Lin D, Schade G, Liao J, Hsieh A, Yezefski T, Hawley J, Yu E, Montgomery R, Grivas P, Wright J. Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study. Clinical Genitourinary Cancer 2024, 22: 102208. PMID: 39265260, DOI: 10.1016/j.clgc.2024.102208.Peer-Reviewed Original ResearchSmall cell bladder cancerConcurrent chemoradiotherapyNeoadjuvant chemotherapySEER-Medicare databaseMedian OSLocoregional therapySEER-MedicareBladder cancerHistological subtypesOverall survivalInstitutional databaseCompare outcomesOptimal locoregional therapyAggressive histologic subtypeNon-metastatic stageNon-metastatic diseaseSEER-Medicare datasetMultivariate Cox analysisFollow-up/deathLocalized diseaseCox analysisCystectomyTreatment patternsTreatment responseMultivariate analysis
2015
Unplanned Hospital Return for Infection following Ureteroscopy—Can We Identify Modifiable Risk Factors?
Moses R, Ghali F, Pais V, Hyams E. Unplanned Hospital Return for Infection following Ureteroscopy—Can We Identify Modifiable Risk Factors? Journal Of Urology 2015, 195: 931-936. PMID: 26410731, DOI: 10.1016/j.juro.2015.09.074.Peer-Reviewed Original ResearchConceptsAntibiotic prophylaxisGenitourinary infectionsUnplanned returnOperative timeLaser lithotripsyPreoperative stentingMultivariate analysisAUA Best Practice StatementPractice statementsHospital returnAppropriate prophylaxis strategiesOptimal prophylaxis regimensModifiable risk factorsRetrospective chart reviewLonger operative timeSingle academic institutionType/durationRate of infectionProphylaxis regimensChart reviewInpatient readmissionsPatient demographicsProphylaxis strategiesRisk factorsHigh risk